Soliton, a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (MD Anderson),
The post Soliton announces IRB approval for Keloid Trial appeared first on NS Medical Devices.
Original Article: Soliton announces IRB approval for Keloid Trial